CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response

BACKGROUND: Soft tissue sarcomas (STS) are heterogeneous and pro-metastatic tumors. Identification of accurate prognostic factors and novel therapeutic targets are crucial. CSPG4 is a cell surface proteoglycan with oncogenic functions. It recently emerged as a potential target for immunotherapy, inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Boudin, Laurys, de Nonneville, A, Finetti, Pascal, Mescam, Léna, Le Cesne, A, Italiano, Antoine, Blay, Jean-Yves, Birnbaum, Daniel, Mamessier, Emilie, Bertucci, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552405/
https://www.ncbi.nlm.nih.gov/pubmed/36221119
http://dx.doi.org/10.1186/s12967-022-03679-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552405/
https://www.ncbi.nlm.nih.gov/pubmed/36221119
http://dx.doi.org/10.1186/s12967-022-03679-y

Ejemplares similares